Search results for "Myocardial infarction"
Antibody therapy gets EUA, studies show pandemic's effects on emergency care
Sotrovimab received an emergency use authorization (EUA) for some high-risk outpatients with COVID-19, and multiple studies found changed patterns in cardiac emergencies and care associated with the pandemic.
https://immattersacp.org/weekly/archives/2021/06/08/1.htm
8 Jun 2021
Three months after PCI, discontinuing aspirin associated with less bleeding than continued dual antiplatelet therapy
High-risk patients who were randomized to switch to ticagrelor plus placebo had similar rates of cardiovascular events as those who continued ticagrelor plus aspirin, an industry-funded trial found.
https://immattersacp.org/weekly/archives/2019/10/08/2.htm
8 Oct 2019
MKSAP Quiz: Shortness of breath following hospital discharge
A 52-year-old woman is evaluated during a follow-up visit following a small non–ST-elevation myocardial infarction treated with drug-eluting stent. Since discharge, she has had shortness of breath. Following a physical exam and chest radiograph, what is the most likely cause of this patient's dyspnea?
https://immattersacp.org/weekly/archives/2018/10/30/3.htm
30 Oct 2018
Diuretics may be superior to ACE inhibitors for initial hypertension monotherapy
Angiotensin-converting enzyme (ACE) inhibitors appeared only modestly less effective than thiazide or thiazide-like diuretics, but the effect of initial monotherapy with the latter across the whole population could be substantial, the study authors concluded.
https://immattersacp.org/weekly/archives/2019/11/05/2.htm
5 Nov 2019
Age only one consideration in post-MI drug therapy
To determine the best therapy for elderly patients after a heart attack, physicians should get to know their goals for their lives.
https://immattersacp.org/archives/2020/09/age-only-one-consideration-in-post-mi-drug-therapy.htm
1 Sep 2020
Adding colchicine after MI may reduce cardiovascular events
While a trial found that low-dose colchicine reduced cardiovascular events after myocardial infarction (MI) significantly more than placebo, there are unresolved questions about inflammation as a therapeutic target, an accompanying editorial noted.
https://immattersacp.org/weekly/archives/2019/11/26/1.htm
26 Nov 2019
After PCI, 5-year revascularization, MACE rates higher in women than men
Researchers pooled patient-level data from 21 randomized trials of bare-metal and drug-eluting stents.
https://immattersacp.org/weekly/archives/2020/04/07/5.htm
7 Apr 2020
Remote monitoring successfully replaced some visits in post-MI care, study finds
Patients in the study's intervention group were given four smartphone-compatible devices: a scale, a blood pressure monitor, a heart rhythm monitor, and a step counter.
https://immattersacp.org/weekly/archives/2020/04/21/6.htm
21 Apr 2020
Fasting may not be necessary before lipids testing, study finds
In this post hoc follow-up analysis of a randomized clinical trial, triglyceride levels were slightly higher in nonfasting samples than fasting samples, and cholesterol levels in both types of samples were similar.
https://immattersacp.org/weekly/archives/2019/06/04/4.htm
4 Jun 2019
Metoprolol not effective for reducing time to COPD exacerbation
A randomized placebo-controlled trial, which was stopped early due to safety and futility concerns, found no significant between-group difference in median time to first exacerbation of chronic obstructive pulmonary disease (COPD).
https://immattersacp.org/weekly/archives/2019/10/29/4.htm
29 Oct 2019